Liraglutide

Definition

A daily-injection GLP-1 receptor agonist marketed as Victoza (for type 2 diabetes, 1.2 / 1.8 mg) and Saxenda (for chronic weight management, 3.0 mg). Daily subcutaneous administration distinguishes it from the weekly GLP-1s. Elimination half-life ~13 hours. The LEADER trial established its cardiovascular benefit in T2D.

Saxenda drug page →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in drug

• Exenatide
• Dulaglutide
• Albiglutide
• Contrave
• Qsymia
• Bupropion
• Naltrexone
• Phentermine
• Topiramate
• Pemvidutide
• Mazdutide

Looking for more depth?

• Saxenda drug page
• Browse the full GLP-1 glossary (124 terms across 8 categories)
• Research articles — primary-source deep dives
• Tools and calculators
• Compare GLP-1 telehealth providers